Translate

Saturday, March 16, 2019

Amidst global recalls, regulator gives nod for new generic Valsartan

This week, the US Food and Drug Administration approved a new generic version of Diovan (valsartan), an angiotensin II receptor blocker (ARB) that tre
Source: BHT